People urged to join first ‘Sunset Run’ to support vital cancer research

People are being encouraged to sign up for a new ‘Sunset Run’ at Nottingham Trent University – in support of its John van Geest Cancer Research Centre.

Bookings are now open for the event at the Clifton Campus on Tuesday May 7, which begins at 6.30pm and will feature a 5K run and a 1.5K fun run.

All the money raised will go towards the ground-breaking work at NTU’s cancer research centre – which aims to save lives and speed patient recovery by improving the diagnosis and treatment of a range of cancers.

Established in 2008, the centre has pioneered innovative approaches for improving the diagnosis of cancer, better predicting how the disease will respond to therapy and for boosting the immune system to fight cancer, known as immunotherapy.

Important work has included developing a simple blood test which can confirm the presence of prostate cancer and identifying a breast cancer protein which indicates whether a patient is likely to respond to chemotherapy.

The centre has also just announced that it has found that ‘cancer-killing’ white blood cells from patients with prostate cancer, part of the body’s natural immune system, can be triggered to fight the disease.

The Sunset Run is open to all and will feature entertainment and a barbecue at the finish.

Participants will pay a small entrance fee and are being urged to raise as much as they can, either individually or in groups.

Danielle Russell, Head of Alumni Relations and Regular Giving at Nottingham Trent University, said: “This exciting new event will offer participants the opportunity to make the most of a Spring evening and join people from across Nottingham in a run to raise money for the John van Geest Cancer Research Centre.

“Not only will this be an enjoyable evening for all, runners will directly be helping our scientists enable breakthroughs in cancer research.”

Professor Graham Pockley, Director of NTU’s John van Geest Cancer Research Centre, added: “Every penny raised will go towards the research which is making big advances towards the more effective diagnosis, management and treatment of a range of cancers.”